Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection has claimed
millions of lives since late 2019, yet there are still many unexplored areas in its …

Background: With an increasing number of patients experiencing infertility due to chronic
salpingitis after Chlamydia trachomatis (CT) infection, there is an unmet need for tissue …

The use of natural compounds, such as curcumin, to treat infections caused by bacteria,
viruses, fungi, parasites, inflammatory diseases, and various types of cancer is an active and …

MSC (aka mesenchymal stem cell or medicinal signaling cell) cell therapies show promise
in decreasing mortality in acute respiratory distress syndrome (ARDS) and suggest benefits …

Mesenchymal stem cell (MSC) therapy is considered one of the most promising treatments
in the context of the coronavirus disease 2019 (COVID-19) pandemic. However, the safety …

Rationale: Early post injury mitigation strategies in ARDS are in short supply. Treatments
with allogeneic stromal cells are administered after ARDS develops, require specialized …

Background Mesenchymal stem/stromal cells (MSCs) and their secreted products are a
promising therapy for COVID-19 given their immunomodulatory and tissue repair …

Abstract Mesenchymal Stem Cells (MSCs) are non‐hematopoietic and multipotent stem
cells, which have been considered in regenerative medicine. These cells are easily …

Background Critical limb ischemia (CLI) is associated with increased risk of tissue loss,
leading to significant morbidity and mortality. Therapeutic angiogenesis using cell-based …

Previously, we demonstrated the therapeutic effects of human umbilical cord mesenchymal
stromal cells (hUC-MSCs) in severe coronavirus disease 2019 (COVID-19) patients. In this 3 …